Edition:
United States

Cegedim SA (CGDM.PA)

CGDM.PA on Paris Stock Exchange

35.40EUR
23 Apr 2018
Change (% chg)

€0.20 (+0.57%)
Prev Close
€35.20
Open
€35.30
Day's High
€35.60
Day's Low
€35.00
Volume
5,772
Avg. Vol
10,661
52-wk High
€44.50
52-wk Low
€23.94

Latest Key Developments (Source: Significant Developments)

Bpifrance Announces Sale Of 1,682,146 Shares In Cegedim For ‍c.59 Million Euros​
Tuesday, 13 Feb 2018 02:00am EST 

Feb 13 (Reuters) - Bpifrance::.  Full Article

Bpifrance Announces Sale Of Its Cegedim's Shares, For 9 To 12 Percent Of Capital
Monday, 12 Feb 2018 12:13pm EST 

Feb 12 (Reuters) - Bpifrance: :SALE OF CEGEDIM SA<<>> SHARES HELD BY BPIFRANCE FOR 9% TO 12% OF CAPITAL .SHARES HELD BY BPIFRANCE FOR 9% TO 12% OF CAPITAL .FREE-FLOAT TO INCREASE TO REACH MAX OF 44.1% OF CAPITAL - BPI FRANCE.FOLLOWING SETTLEMENT, BPIFRANCE PARTICIPATIONS WILL SELL A MAXIMUM OF 12% OF CEGEDIM’S CAPITAL .THEREFORE, BPIFRANCE PARTICIPATIONS WILL POTENTIALLY BREACH DOWNWARDS 5% THRESHOLD.  Full Article

Cegedim Q4 Consolidated Revenue Up 6.3 Percent At 126.5 Million Euros
Monday, 29 Jan 2018 11:48am EST 

Jan 29 (Reuters) - Cegedim Sa ::OUTLOOK FOR CONSOLIDATED 2017 EBITDA RAISED SIGNIFICANTLY.NOW EXPECTS 2017 EBITDA FROM CONTINUING ACTIVITIES TO EXCEED EUR 72 MILLION..CONSOLIDATED Q4 2017 REVENUES FROM CONTINUING ACTIVITIES OF EUR 126.5 MILLION, UP 6.3% ON A REPORTED BASIS.  Full Article

Cegedim ‍Sells Cegelease Business to Société Générale​
Thursday, 14 Dec 2017 11:45am EST 

Dec 14 (Reuters) - CEGEDIM SA ::‍SALE OF CEGELEASE BUSINESS​.DEAL IS EXPECTED TO CLOSE DURING Q1 OF 2018.GROUP IS NOT PLANNING ANY OTHER DIVESTMENT.SIGNS A SALES AGREEMENT WITH SOCIÉTÉ GÉNÉRALE.SALE PRICE IS EUR 57.5 MILLION, PLUS REIMBURSEMENT OF SHAREHOLDER'S LOAN ACCOUNT, WHICH AMOUNTED TO EUR 13 MILLION ON JUNE 30..WILL USE EUR 30 MILLION TO PAY DOWN ITS DEBT.  Full Article

Cegedim Chosen By Nimes Mutual Health Center To Manage Medical Records And Patient Administration‍​
Monday, 27 Nov 2017 12:12pm EST 

Nov 27 (Reuters) - CEGEDIM SA ::CHOSEN BY NIMES MUTUAL HEALTH CENTER TO MANAGE MEDICAL RECORDS AND PATIENT ADMINISTRATION‍​.  Full Article

Cegedim: Cegedim Insurance Solutions partners with Humanis to expand its third-party payment service‍​
Tuesday, 21 Nov 2017 12:02pm EST 

Nov 21 (Reuters) - CEGEDIM SA ::CEGEDIM INSURANCE SOLUTIONS PARTNERS WITH HUMANIS TO EXPAND ITS THIRD-PARTY PAYMENT SERVICE‍​.ISANTÉ THIRD-PARTY PAYMENT SYSTEM CONTRACT RENEWED AND EXPANDED.CHANGES INCLUDING STRONGER SERVICE-LEVEL COMMITMENTS AND WIDER RANGE OF SERVICES AS PART OF NEW AGREEMENT.  Full Article

Neovacs H1 net loss widens to 8.1‍​ million euros
Friday, 27 Oct 2017 11:45am EDT 

Oct 27 (Reuters) - NEOVACS SA ::H1 NET LOSS EUR 8.1‍​ MILLION VERSUS LOSS OF EUR 6.8 MILLION YEAR AGO.H1 OPERATING LOSS EUR 10.2‍​ MILLION VERSUS LOSS OF EUR 7.9 MILLION YEAR AGO.H1 REVENUE EUR ‍​0.5 MILLION VERSUS EUR 0.1 MILLION YEAR AGO.‍CASH AND CASH EQUIVALENTS AT JUNE 30, 2017, AMOUNTED TO EUR 1.8 MLN​.‍TO OBTAIN RESULTS FROM PHASE IIB CLINICAL TRIAL IN LUPUS IN JUNE 2018​‍​.  Full Article

Cegedim Q3 revenue rises to 109.3‍​ million euros
Thursday, 26 Oct 2017 11:50am EDT 

Oct 26 (Reuters) - CEGEDIM SA ::9M REVENUE EUR 339.9‍​ MILLION VERSUS EUR 318.3 MILLION YEAR AGO.Q3 REVENUE EUR 109.3‍​ MILLION VERSUS EUR 102.8 MILLION YEAR AGO.GROWTH SHOULD ACCELERATE IN Q4 2017 AND ENSURE, IN THE FUTURE, IMPROVED PROFITABILITY.IN 2017, THE GROUP DOES NOT ANTICIPATE ANY SIGNIFICANT ACQUISITIONS.MAINTAINS 2017 TARGETS.DOES NOT COMMUNICATE FORECASTS OR PROFIT ESTIMATES FOR 2017.  Full Article

Cegedim sees FY lfl revenue growth slightly above previous forecast range of between 4 and 6 percent
Thursday, 21 Sep 2017 01:13pm EDT 

Sept 21 (Reuters) - CEGEDIM SA ::FY 2017 REVENUE TARGET REVISED UPWARD‍​.GROUP REITERATES ITS EBITDA FORECAST.NET PROFIT BEFORE SPECIAL ITEMS CAME TO EUR 0.0 LOSS PER SHARE IN FIRST HALF OF 2017, COMPARED WITH EUR 1.1 LOSS A YEAR EARLIER.RAISES OUTLOOK FOR LIKE-FOR-LIKE REVENUE GROWTH, WHICH IS LIKELY TO BE SLIGHTLY ABOVE PREVIOUSLY ANNOUNCED FORECAST RANGE OF BETWEEN 4.0% AND 6.0%.CEGEDIM EXPECTS TO SEE THE FULL POSITIVE IMPACT OF ITS INVESTMENTS, REORGANIZATION AND TRANSFORMATION IN 2018.DOES NOT EXPECT ANY SIGNIFICANT ACQUISITIONS IN 2017 AND DOES NOT DISCLOSE EARNINGS PROJECTIONS OR ESTIMATES.BREXIT IS UNLIKELY TO HAVE A MATERIAL IMPACT ON GROUP EBIT.REGARDING HEALTHCARE POLICY, GROUP HAS NOT IDENTIFIED ANY MAJOR EUROPEAN PROGRAMS AT WORK IN UK AND EXPECTS UK POLICY TO BE ONLY MARGINALLY AFFECTED BY BREXIT.H1 EBITDA EUR 33.2 MILLION VERSUS EUR 26.8 MILLION YEAR AGO.  Full Article

Cegedim Q2 revenue raises to 116.9 million euros
Thursday, 27 Jul 2017 11:46am EDT 

July 27 (Reuters) - CEGEDIM SA ::Q2 REVENUE EUR 116.9 MILLION VERSUS EUR 109.3 MILLION YEAR AGO.IS REITERATING ITS FULL-YEAR OUTLOOK.FY2017 OUTLOOK: REVENUE GROWTH BETWEEN 4.0% AND 6.0%..FY2017 OUTLOOK: EBITDA IN A RANGE OF €66.0 MILLION TO €72.0 MILLION INCLUSIVE.FY2017 OUTLOOK: DOES NOT EXPECT ANY SIGNIFICANT ACQUISITIONS IN 2017.  Full Article